Qualitative high performance thin layer chromatography (HPTLC) analysis of cannabinoids in urine samples of Cannabis abusers

Indian Journal of Medical Research

Volumn 132, Issue 8, 2010, Pages 201-208

  Sharma, Priyamvada ^a   Srinivas Bharath, M M ^a   Murthy, Pratima ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cannabinoids; Cannabis; Deaddiction; Drug abuse; Thin layer chromatography

Indexed keywords

4 DIMETHYLAMINOBENZALDEHYDE; CANNABINOID; FAST BLUE; TETRAHYDROCANNABINOLIC ACID;

ADULT; ARTICLE; CANNABIS ADDICTION; COST EFFECTIVENESS ANALYSIS; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; LIQUID LIQUID EXTRACTION; MAJOR CLINICAL STUDY; MALE; REPRODUCIBILITY; STANDARDIZATION; URINALYSIS; CANNABIS SMOKING; EVALUATION; INDIA; ISOLATION AND PURIFICATION; METHODOLOGY; THIN LAYER CHROMATOGRAPHY; URINE;

ADULT; CANNABINOIDS; CHROMATOGRAPHY, THIN LAYER; HUMANS; INDIA; MALE; MARIJUANA SMOKING;

EID: 77956093643     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. JAMA 1990; 264: 2511-8.
2. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophrenia Res 2001; 48: 69-82.
3. Tiihonen J, Isohanni M, Rasanen P, Koiranen M, Moring J. Specifc major mental disorders and criminality: a 26-year prospective study of the 1966 northern Finland birth cohort. Am J Psychiatry 1997; 154: 840-5.
4. Arseneault L, Mofftt TE, Caspi A, Taylor PJ, Silva PA. Mental disorders and violence in a total birth cohort: Results from the Dunedin study. Arch Gen Psychiatry 2000; 57: 979-86.
5. Thirthalli J, Benegal V. Psychosis among substance users. Curr Opin Psychiatry 2006; 19: 239-45.
6. Chopra GS. Marijuana and adverse psychotic reactions. Evaluation of different factors involved. Bull Narc 1971; 23: 15-22.
7. Sarkar J, Murthy P, Singh SP. Psychiatric morbidity of cannabis abuse. Indian J Psychiatry 2003; 45: 182-8.
8. Kulhalli V, Isacc M, Murthy P. Cannabis related psychosis: Presentation and effect of abstinence. Indian J Psychiatry 2007; 49: 256-61.
9. King LA, McDermott SD. Drugs of abuse. In: Moffat AC, Osselton MD, Widdop B, editors. Clarke's analysis of drugs and poisons. London: Pharmaceutical Press; 2004. p. 37-53.
10. th ed. New York: Macmillan; 1980. p. 636-8.
11. 9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis. J Anal Toxicol 2007; 31: 477-85.
12. Jeffery W. Colour tests. In: Moffat AC, Osselton MD, Widdop B, editors. Clarke's analysis of drugs and poisons. London: Pharmaceutical Press; 2004. p. 279-300.
13. Baker PB, Fowler R, Bagon KR, Gough TA. Determination of the distribution of cannabinoids in cannabis resin using high performance liquid chromatography. J Anal Toxicol 1980; 4: 145-52.
14. Bourquin D, Brenneisen R. Confrmation of cannabis abuse by the determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine with high-performance liquid chromatography and electrochemical detection. J Chromatogr 1987; 414: 187-91.
15. Isenschmid DS, Caplan YH. A method for the determination of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in urine using high performance liquid chromatography with electrochemical detection. J Anal Toxicol 1986; 10: 170-4.
16. Harvey DJ, Paton WD. Use of trimethylsilyl and other homologous trialkylsilyl derivatives for the separation and characterization of mono and di-hydroxy cannabinoids by combined gas chromatography and mass spectrometry. J Chromatogr 1975; 109: 73-80.
17. Frederick DL, Green J, Fowler MW. Comparison of six cannabinoid metabolite assays. J Anal Toxicol 1985; 9: 116-20.
18. 9-tetrahydrocannabinol 9-carboxylic acid in urine specimens. Forensic Sci Int 1991; 49: 43-56.
19. Altunkaya D, Clatworthy AJ, Smith RN, Start IJ. Urinary cannbinoid analysis: comparison of four immunoassays with gas chromatography-mass spectrometry. Forensic Sci Int 1991; 50: 15-22.
20. Korte T, Pykalainen J, Lillsunde P, Seppala T. Comparison of RapiTest with Emit d.a.u and GC-MS for the analysis of drugs in urine. J Anal Toxicol 1997; 21: 49-53.
21. Fraser AD, Worth D. Monitoring urinary excretion of cannabinoids by fuorescence-polarization immunoassay: a cannabinoid to creatinine ratio study. Ther Drug Monit 2002; 24: 746-50.
22. Debruyne D, Albessard F, Bigot MC, Moulin M. Comparison of three advanced chromatographic techniques for cannabis identifcation. Bull Narc 1994; 46: 109-21.
23. Meatherall RC, Garriott JC. A sensitive thin-layer chromatographic procedure for the detection of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. J Anal Toxicol 1988; 12: 136-40.
24. Jain R, Ray R. Detection of drugs of abuse and its relevance to clinical practice. Indian J Pharmacol 1995; 27: 1-6.
25. Jain R. Interference of adulterants in thin layer chromatography method for drugs of abuse. Indian J Pharmacol 1993; 25: 240-2.
26. Galand N, Ernouf D, Montigny F, Dollet J, Pothier J. Separation and identifcation of cannabis components by different planer chromatography techniques (TLC, AMD, OPLC). J Chromatogr Sci 2004; 42: 130-4.
27. Uges DRA. Hospital toxicity. In: Moffat AC, Osselton MD, Widdop B, editors. Clarke's analysis of drugs and poisons. London: Pharmaceutical Press; 2004. p. 3-36.
28. 9-tetrahydrocannabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol 2008; 32: 562-9.
29. Poole CF. Thin layer chromatography. In: Moffat AC, Osselton MD, Widdop B, editors. Clarke's analysis of drugs and poisons. London: Pharmaceutical Press; 2004. p. 392-424.
30. Nikonova EV, Karaeva LD. Use of thin-layer chromatography for detection of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine. Sud Med Ekspert 2005; 48: 33-5.
31. Kaistha KK, Tadrus R. Semi-quantitative thin-layer mass-screening detection of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in human urine. J Chromatogr 1982; 237: 528-33.
32. Novakova E. Detection of 11-nor-9-tetrahydrocannabinol-9-carboxylic acid in urine using thin-layer chromatography. Soud Lek 1997; 42: 5-8.
33. Schwartz RH. Urine testing in the detection of drugs of abuse. Arch Intern Med 1988; 148: 2407-12.
34. Schwartz RH, Willette RE, Hayden GF, Bogema S, Thorne MM, Hicks J. Urinary cannabinoids in monitoring abstinence in a drug abuse treatment program. Arch Pathol Lab Med 1987; 111: 708-11.
35. Poortman-van der Meer AJ, Huizer H. A contribution to the improvement of accuracy in the quantitation of THC. Forensic Sci Int 1999; 101: 1-8.